The Pilot &Feasibility Program has been markedly successful over our first DRC/DRTC cycle. We have impelled career development of junior investigators who received most of these awards (70%), launched innovative projects, and enticed established investigators in other areas to apply their expertise to the study of diabetes. We have had robust responses (average 43/year) to our RFAs every year, and have leveraged institutional support to fund numbers of grants beyond that made possible by NIH support;39 pilots have been awarded to-date, 26 from the NIH DRC allocation, 4 from institutional funds through the Comprehensive Diabetes Center, and 9 through ARRA supplements. All funded applications were judged to be highly meritorious by a rigorous NIH study section-style review process consisting of intramural and extramural experts with an average funding rate of 18%. Recipients have taken advantage of these awards by publishing manuscripts, submitting extramural research applications, and securing larger funding to continue the line of investigation initiated with the pilot award. The pilot program has been a critical tool responsible for the growth in membership numbers and extramural funding of our DRTC/DRC since 2008. Our overall goal for the Pilot &Feasibility Program continues to be to faculitate new research development through pilot projects that synergize with other Cores and Programs in a manner that promotes the overall goals and objectives of the DRC.
The specific aims are: 1.To identify and support new research projects of outstanding quality and innovation for pilot funding, ultimately resulting in larger extramural support for development of the new line of investigation. 2.To support promising junior faculty in career development through funding of outstanding pilot research. 3.To augment the breadth and quality of DRC research by funding innovative projects of established researchers with valuable expertise who are new to diabetes, or of established diabetes investigators who want to test new high-impact hypotheses. 4.To increase the number of independent investigators funded by NIH to conduct diabetes research.
Diabetes is reaching epidemic proportions in the US and the developing world as a whole. The Deep South has suffered a disproportionate increase in the incidence and prevalence of diabetes. In fact, the state of Alabama and surrounding Southeast region served by UAB may be considered the epicenter of the epidemic. Our DRC pilot program will serve as a beacon to address this problem, fostering development of inovative diabetes research and researchers .
|Misra, Devyani; Felson, David T; Silliman, Rebecca A et al. (2015) Knee osteoarthritis and frailty: findings from the Multicenter Osteoarthritis Study and Osteoarthritis Initiative. J Gerontol A Biol Sci Med Sci 70:339-44|
|Panwar, Bhupesh; Hanks, Lynae J; Tanner, Rikki M et al. (2015) Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int 87:1216-22|
|Casazza, Krista; Brown, Andrew; Astrup, Arne et al. (2015) Weighing the Evidence of Common Beliefs in Obesity Research. Crit Rev Food Sci Nutr 55:2014-53|
|Harper, Lorie M; Tita, Alan; Biggio, Joseph R (2015) The institute of medicine guidelines for gestational weight gain after a diagnosis of gestational diabetes and pregnancy outcomes. Am J Perinatol 32:239-46|
|Cree-Green, Melanie; Newcomer, Bradley R; Brown, Mark S et al. (2015) Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance. Diabetes 64:383-92|
|Bone, Robert N; Gai, Ying; Magrioti, Victoria et al. (2015) Inhibition of Ca2+-independent phospholipase A2? (iPLA2?) ameliorates islet infiltration and incidence of diabetes in NOD mice. Diabetes 64:541-54|
|Carson, April P; Steffes, Michael W; Carr, J Jeffrey et al. (2015) Hemoglobin a1c and the progression of coronary artery calcification among adults without diabetes. Diabetes Care 38:66-71|
|Clement, Lionel C; Macé, Camille; Del Nogal Avila, Maria et al. (2015) The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome. Transl Res 165:499-504|
|Hanks, Lynae J; Casazza, Krista; Ashraf, Ambika P et al. (2015) Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females. Clin Endocrinol (Oxf) 82:550-6|
|Armstrong, Anderson C; Liu, Kiang; Lewis, Cora E et al. (2014) Left atrial dimension and traditional cardiovascular risk factors predict 20-year clinical cardiovascular events in young healthy adults: the CARDIA study. Eur Heart J Cardiovasc Imaging 15:893-9|
Showing the most recent 10 out of 154 publications